Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

March 20, 2017

Sanofi-Aventis U.S., LLC et al v. Amgen Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 21, 2017

    Sanofi Sues Amgen To Protect Eczema Drug From IP Claims

    Sanofi SA and partner Regeneron Pharmaceuticals sued Amgen Inc. in Massachusetts federal court, seeking a court order declaring that its eczema drug Dupixent doesn’t infringe an Amgen Inc. patent for a failed asthma treatment and to thwart anticipated litigation against it.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login